Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2010
07/20/2010US7758867 prepared by mating isolated strains; for prevention of seasonal and sudden outbreaks
07/20/2010US7758866 human papillomavirus (HPV); virus-like particles, capsomers; immunogens
07/20/2010US7758865 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs
07/20/2010US7758863 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
07/20/2010US7758862 Hepatocyte growth factor receptor splice variants and methods of using same
07/20/2010US7758859 monoclonal antibody or an Fab fragment capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, age-induced macular degeneration
07/20/2010US7758858 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders
07/20/2010US7758856 Bacteriophage for the treatment of bacterial biofilms
07/20/2010US7758855 DNA promoters and anthrax vaccines
07/20/2010US7758852 OX40R binding agents
07/20/2010CA2446942C Use of il-18 inhibitors for the treatment or prevention of sepsis
07/20/2010CA2421339C Novel polypeptides and nucleic acids encoding the same
07/20/2010CA2410586C Recombinant or purified polyclonal antibodies for treating allergy
07/20/2010CA2394648C Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen
07/20/2010CA2309679C Method of identifying binding site domains that retain the capacity of binding to an epitope
07/20/2010CA2289980C Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
07/20/2010CA2271249C Macromolecular neuraminidase-binding compounds
07/20/2010CA2212896C Oral vaccine against gram negative bacterial infection
07/20/2010CA2197563C Capsular polysaccharide immunomodulator
07/20/2010CA2191063C Dna encoding glutamate gated chloride channels
07/15/2010WO2010081173A2 Modified antibody compositions, methods of making and using thereof
07/15/2010WO2010081095A2 Methods and compositions for inhibiting hepatitis c virus replication
07/15/2010WO2010081026A1 Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
07/15/2010WO2010081004A1 Weekly dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugates
07/15/2010WO2010080833A1 Treatment of mucositis with kallikrein inhibitors
07/15/2010WO2010080782A2 Random homozygous gene perburbation (rhgp) with thermal assymetric interlaced (tail)-pcr
07/15/2010WO2010080623A2 Anti-fxi antibodies and methods of use
07/15/2010WO2010080538A1 Covalent diabodies and uses thereof
07/15/2010WO2010080528A1 Hepatitis c virus combination therapy
07/15/2010WO2010080484A1 Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon
07/15/2010WO2010080463A1 Antibody humanization
07/15/2010WO2010080188A2 Epitope targeted anthrax vaccine
07/15/2010WO2010079991A2 Vector for treatment vaccine for stable and constitutive high-expression cervical cancer and recombinant lactobacillus transformed by the same
07/15/2010WO2010079858A1 Novel bacteria-specific lysine proteins with broad antibacterial activity
07/15/2010WO2010079850A2 Agent for prophylaxis or treatment of cancer
07/15/2010WO2010079833A1 Novel cancer antigen eef2
07/15/2010WO2010079510A2 Anti-rhd monoclonal antibodies
07/15/2010WO2010079505A2 Combined measles-human papilloma vaccine
07/15/2010WO2010079464A1 Cna_b domain antigens in vaccines against gram positive bacteria
07/15/2010WO2010079161A1 A b cell depleting agent for the treatment of atherosclerosis
07/15/2010WO2010079081A1 Methods for recovering a virus or a viral antigen produced by cell culture
07/15/2010WO2010057985A3 Salmonella marker vaccine
07/15/2010WO2010054654A4 Modified cationic liposome adjuvans
07/15/2010WO2010044921A3 Intranasal administration of receptor-binding ligands or genes encoding such ligands
07/15/2010WO2010042644A3 Methods for inducing a sustained immune response againts a b-cell idiotype using autologous anti-idiotypic vaccines
07/15/2010WO2010040136A3 Selection of hiv vaccine antigens by use of intrapatient sequence variation to identify mutations in the hiv envelope glycoprotein that affect the binding of broadly neutralizing antibodies
07/15/2010WO2010029513A3 Pcsk9 antagonists
07/15/2010WO2010028313A3 Phosphoprotein analysis of carcinomas for assessment of drug sensitivity
07/15/2010WO2010025400A3 Cross-reactive and bispecific anti-el 17a/f antibodies
07/15/2010WO2010011870A3 Compositions and methods for the treatment of hepatitis c
07/15/2010WO2009155726A3 Humanization of rabbit antibodies using a universal antibody framework
07/15/2010WO2009147248A3 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
07/15/2010WO2009142810A3 Methods for treating or preventing colorectal cancer
07/15/2010WO2009103821A3 Regulators of pb1-f2 activity for treating virus infections
07/15/2010WO2009090082A3 Bacteriophage preparation and use
07/15/2010WO2009033282A8 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects
07/15/2010US20100179515 Tissue roll scaffolds
07/15/2010US20100178331 Preparation for transnasal application
07/15/2010US20100178304 Method for silk fibroin gelation using sonication
07/15/2010US20100178303 Stable organic-carrier-based microbial inoculants and method for producing the same
07/15/2010US20100178302 Chronic pathogen-expressing cell lines
07/15/2010US20100178301 Method of treating pregnant cows and/or heifers
07/15/2010US20100178299 Methods and compositions for improving immune responses
07/15/2010US20100178298 Destruction of Tumor Cells by Trifunctional Bispecific Antibodies With Low to Medium Expression Levels of Tumor-Associated Target Antigens
07/15/2010US20100178297 Means and methods for the recruitment and identification of stem cells
07/15/2010US20100178296 Antibodies to cd200r
07/15/2010US20100178295 Compositions and methods for the therapy and diagnosis of influenza
07/15/2010US20100178294 Macrocyclic beta-secretase inhibitors
07/15/2010US20100178293 Use of antibodies against the cd52 antigen for the treatment of neurological disorders, particularly transmissible spongiform encephalopathy and alzheimer's disease
07/15/2010US20100178292 Cryptic glycan markers and applications thereof
07/15/2010US20100178291 Pyrrolidinone, Pyrrolidine-2, 5-Dione, Pyrrolidine and Thiosuccinimide Derivatives, Compositions and Methods for Treatment of Cancer
07/15/2010US20100178290 Methods for reducing viral load in HIV-1 infected patients
07/15/2010US20100178289 THERAPEUTIC USE OF IgG AS A NEUROPROTECTIVE AGENT
07/15/2010US20100178251 Dual-Sensitizer-Containing Luminescent Compounds, Conjugates, and Uses Thereof
07/15/2010CA2750785A1 Random homozygous gene perburbation (rhgp) with thermal assymetric interlaced (tail)-pcr
07/15/2010CA2749367A1 Cna_b domain antigens in vaccines against gram positive bacteria
07/15/2010CA2749339A1 Modified antibody compositions, methods of making and using thereof
07/15/2010CA2749115A1 Weekly dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugates
07/15/2010CA2748819A1 Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
07/15/2010CA2747519A1 Anti-fxi antibodies and methods of use
07/15/2010CA2747248A1 Hepatitis c virus combination therapy
07/15/2010CA2746350A1 Anti-rhd monoclonal antibodies
07/15/2010CA2745460A1 Covalent diabodies and uses thereof
07/15/2010CA2744670A1 A b cell depleting agent for the treatment of atherosclerosis
07/15/2010CA2744235A1 Treatment of mucositis with kallikrein inhibitors
07/15/2010CA2743708A1 Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon dioxide
07/15/2010CA2722847A1 Combined measles-human papilloma vaccine
07/14/2010EP2206785A1 Improved expression of HIV polypeptides and production of virus-like particles
07/14/2010EP2206775A1 Anti-il-6 receptor antibody
07/14/2010EP2206728A1 Methods for treating bone cancer pain by administering a nerve growth factor antagonistic antibody
07/14/2010EP2206727A1 ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15
07/14/2010EP2206720A1 Albumin fusion proteins
07/14/2010EP2206517A1 Immunopotentiating compositions comprising anti-PD-L1 antibodies
07/14/2010EP2206516A1 Stabilized liquid anti-RSV antibody formulations
07/14/2010EP2206515A1 Combination vaccines with whole cell pertussis antigen
07/14/2010EP2206514A2 Recombinant intracellular pathogen immunogenic compositions and methods for use
07/14/2010EP2206513A2 A multicomponent or monocomponent vaccine to be used against chagas disease
07/14/2010EP2205721A1 Tr1 cells, mesenchymal stem cells and uses thereof
07/14/2010EP2205640A2 Antibodies that bind il-4 and/or il-13 and their uses
07/14/2010EP2205639A2 Anti-pcsk9 and methods for treating lipid and cholesterol disorders
1 ... 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 ... 1823